Violet Ankunda

ORCID: 0009-0007-2007-679X

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 14 papers. Top paper: “Optimisation and Validation of a conventional ELISA and cut-offs for detecting and quantifying anti-SARS-CoV-2 Spike, RBD, and Nucleoprotein IgG, IgM, and IgA antibodies in Uganda”.

Optimisation and Validation of a conventional ELISA and cut-offs for detecting and quantifying anti-SARS-CoV-2 Spike, RBD, and Nucleoprotein IgG, IgM, and IgA antibodies in Uganda

Frontiers in Immunology(2023)10.3389/fimmu.2023.1113194

N/A

0DataRank · unranked

40 citations

Patricia Namubiru, Laban Kato, Violet Ankunda, Ben Gombe, Matthew Cotten +6 more

Rapid, early, and potent Spike-directed IgG, IgM, and IgA distinguish asymptomatic from mildly symptomatic COVID-19 in Uganda, with IgG persisting for 28 months

Frontiers in Immunology(2023)10.3389/fimmu.2023.1152522

N/A

0DataRank · unranked

20 citations

Violet Ankunda, Jackson Sembera, Laban Kato, Gerald Kevin Oluka, Claire Baine +14 more

Seroprevalence and durability of antibody responses to AstraZeneca vaccination in Ugandans with prior mild or asymptomatic COVID-19: implications for vaccine policy

Frontiers in Immunology(2023)10.3389/fimmu.2023.1183983

N/A

0DataRank · unranked

13 citations

Claire Baine, Susan Mugaba, Violet Ankunda, Betty Oliver Auma, Gerald Kevin Oluka +11 more

Sustained spike-specific IgG antibodies following CoronaVac (Sinovac) vaccination in sub-Saharan Africa, but increased breakthrough infections in baseline spike-naive individuals

Frontiers in Immunology(2023)10.3389/fimmu.2023.1255676

N/A

0DataRank · unranked

9 citations

Claire Baine, Violet Ankunda, Joseph Ssebwana Katende, Gerald Kevin Oluka, Christine Hermilia Akoli +9 more

An Optimised Indirect ELISA Protocol for Detection and Quantification of Anti-viral Antibodies in Human Plasma or Serum: A Case Study Using SARS-CoV-2

BIO-PROTOCOL(2023)10.21769/bioprotoc.4905

N/A

0DataRank · unranked

9 citations

Jackson Sembera, Gerald Kevin Oluka, Joseph Ssebwana Katende, Violet Ankunda, Jennifer Serwanga +1 more

The Distinct Absence of a Post-boost Spike-IgG Antibody Surge in Ugandan Recipients of the Pfizer-BioNTech Vaccine Has Implications for Vaccination Policies

Preprints.org(2023)10.20944/preprints202310.0379.v1

N/A

0DataRank · unranked

1 citations

Violet Ankunda, Joseph Ssebwana Katende, Jackson Sembera, Gerald Kevin Oluka, Claire Baine +5 more

Silent Symptoms, Active Immunity: Insights into Early-Stage Cytokine Expressions in Ugandan Mild and Asymptomatic COVID-19 subjects

Research Square(2023)10.21203/rs.3.rs-3558086/v1

N/A

0DataRank · unranked

0 citations

Violet Ankunda, Ivan Ssali, Gerald Kevin Oluka, Susan Mugaba, Joseph Ssebwana Katende +13 more

The subdued post-boost spike-directed secondary IgG antibody response in Ugandan recipients of the Pfizer-BioNTech BNT162b2 vaccine has implications for local vaccination policies

Frontiers in Immunology(2024)10.3389/fimmu.2024.1325387

N/A

0DataRank · unranked

7 citations

Joseph Ssebwana Katende, Gerald Kevin Oluka, Jackson Sembera, Claire Baine, Geoffrey Odoch +6 more

Persistent and robust antibody responses to ChAdOx1-S Oxford-AstraZeneca (ChAdOx1-S, Covishield) SARS-CoV-2 vaccine observed in Ugandans across varied baseline immune profiles

PLoS ONE(2024)10.1371/journal.pone.0303113

N/A

0DataRank · unranked

5 citations

Gerald Kevin Oluka, Claire Baine, Violet Ankunda, Jackson Sembera, Laban Kato +8 more

The single-dose Janssen Ad26.COV2.S COVID-19 vaccine elicited robust and persistent anti-spike IgG antibody responses in a 12-month Ugandan cohort

Frontiers in Immunology(2024)10.3389/fimmu.2024.1384668

N/A

0DataRank · unranked

2 citations

Laban Kato, Gerald Kevin Oluka, Violet Ankunda, Jackson Sembera, Claire Baine +8 more

The Single-Dose Janssen Ad26.COV2.S COVID-19 Vaccine Elicited Robust and Persistent Anti-Spike IgG Antibody Responses in A 12-Month Ugandan Cohort

Preprints.org(2024)10.20944/preprints202401.0089.v1

N/A

0DataRank · unranked

1 citations

Laban Kato, Violet Ankunda, Isaac Kitabye, Angella Namuyanja, Solomon Opio +7 more

Long-Term Immune Consequences of Initial SARS-CoV-2 A.23.1 Exposure: A Longitudinal Study of Antibody Responses and Cross-Neutralization in a Ugandan Cohort

Vaccines(2025)10.3390/vaccines13020143

N/A

0DataRank · unranked

8 citations

Jackson Sembera, Joseph Ssebwana Katende, Violet Ankunda, Laban Kato, Ashwini Kurshan +8 more

Geographical Differences in SARS-CoV-2 Antibody Response Dynamics and Neutralisation Profiles to Mild COVID-19: Lessons from a UK–Uganda Comparison

Vaccines(2025)10.3390/vaccines13040336

N/A

0DataRank · unranked

2 citations

Jackson Sembera, Gerald Kevin Oluka, Joseph Ssebwana Katende, Juliana Bemanzi, Violet Ankunda +10 more

Long-Term Immune Consequences of Initial SARS-CoV-2 A.23.1 Exposure: A Longitudinal Study of Antibody Responses and Cross-Neutralisation in a Ugandan Cohort

Preprints.org(2025)10.20944/preprints202501.0312.v1

N/A

0DataRank · unranked

3 citations

Jackson Sembera, Joseph Ssebwana Katende, Violet Ankunda, Laban Kato, Ashwini Kurshan +8 more